Critical size defect regeneration by rhPTH-collagen membrane as a new tissue engineering tool
Liliana R Missana1, María V Jammal
1Oral Pathology Department, Laboratory of Experimental Pathology and Tissue Engineering, Dental School, Tucumán University, Tucumán, Argentina; Laboratory of Experimental Pathology and Tissue Engineering, PROIMI-Biotechnology (Pilot Plant for Microbial Industrial Processes and Biotechnology), CONICET, Tucumán, Argentina.
Journal of Biomedical Materials Research. Part A
|March 29, 2014
Summary
A novel biomaterial, the rhPTH and atelocollagen membrane (CrhPTHm), effectively regenerates bone in critical size defects. This tissue engineering tool offers a new method for localized, slow release of recombinant human parathyroid hormone (rhPTH 1-34).
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Surgery
Background:
- Recombinant human parathyroid hormone (rhPTH 1-34) is effective for improving bone mass in osteoporosis.
- Developing innovative tissue engineering tools is crucial for bone regeneration.
- Evaluating novel biomaterials for critical size defect (CSD) repair is an ongoing area of research.
Purpose of the Study:
- To develop a tissue engineering tool for bone regeneration.
- To evaluate the efficacy of a freeze-dried rhPTH membrane in calvarial critical size defects (CSDs).
- To assess the bone regeneration potential of a combined rhPTH and atelocollagen membrane (CrhPTHm).
Main Methods:
- Forty-four Wistar female rats with 5 mm calvarial CSDs were divided into four groups: rhPTH membrane (rhPTHm), atelocollagen membrane (Cm), rhPTH and atelocollagen I (CrhPTHm), and control (CG).
- Samples were evaluated at 1, 3, and 6 weeks post-surgery using soft X-ray, histological, and histometric analyses.
- Bone formation was quantified and compared across groups.
Main Results:
- The CrhPTHm group demonstrated significant bone formation at 3 and 6 weeks (48% and 53%, respectively) compared to the control group (p < 0.05).
- Histological analysis showed replacement of rhPTHm with bone tissue and composite bone formation in the Cm and CrhPTHm groups.
- Soft X-ray revealed radiolucent areas with irregular radiopaque regions, indicating bone regeneration.
Conclusions:
- The combined rhPTH and atelocollagen membrane (CrhPTHm) is an effective biomaterial for regenerating calvarial CSDs.
- This membrane serves as a novel local intermittent delivery system for slow release of rhPTH.
- The findings support the potential of CrhPTHm in advancing bone tissue engineering strategies.
